393 related articles for article (PubMed ID: 18027309)
1. Caffeine consumption amongst British athletes following changes to the 2004 WADA prohibited list.
Chester N; Wojek N
Int J Sports Med; 2008 Jun; 29(6):524-8. PubMed ID: 18027309
[TBL] [Abstract][Full Text] [Related]
2. Distribution of caffeine levels in urine in different sports in relation to doping control before and after the removal of caffeine from the WADA doping list.
Van Thuyne W; Delbeke FT
Int J Sports Med; 2006 Sep; 27(9):745-50. PubMed ID: 16586337
[TBL] [Abstract][Full Text] [Related]
3. [Medication, athletes and doping regulations].
Hartgens F
Ned Tijdschr Geneeskd; 2008 Aug; 152(33):1844-8. PubMed ID: 18783164
[TBL] [Abstract][Full Text] [Related]
4. Condemning and condoning: Elite amateur cyclists' perspectives on drug use and professional cycling.
Outram SM; Stewart B
Int J Drug Policy; 2015 Jul; 26(7):682-7. PubMed ID: 25666447
[TBL] [Abstract][Full Text] [Related]
5. Athletes' knowledge and views on OTC medication.
Mottram D; Chester N; Atkinson G; Goode D
Int J Sports Med; 2008 Oct; 29(10):851-5. PubMed ID: 18401811
[TBL] [Abstract][Full Text] [Related]
6. Ergogenic effects of inhaled beta2-agonists in non-asthmatic athletes.
Wolfarth B; Wuestenfeld JC; Kindermann W
Endocrinol Metab Clin North Am; 2010 Mar; 39(1):75-87, ix. PubMed ID: 20122451
[TBL] [Abstract][Full Text] [Related]
7. Effects of caffeine on prolonged intermittent-sprint ability in team-sport athletes.
Schneiker KT; Bishop D; Dawson B; Hackett LP
Med Sci Sports Exerc; 2006 Mar; 38(3):578-85. PubMed ID: 16540848
[TBL] [Abstract][Full Text] [Related]
8. Influence of performance level on dietary supplementation in elite Canadian athletes.
Erdman KA; Fung TS; Reimer RA
Med Sci Sports Exerc; 2006 Feb; 38(2):349-56. PubMed ID: 16531906
[TBL] [Abstract][Full Text] [Related]
9. Between medical treatment and performance enhancement: an investigation of how elite athletes experience Therapeutic Use Exemptions.
Overbye M; Wagner U
Int J Drug Policy; 2013 Nov; 24(6):579-88. PubMed ID: 23582632
[TBL] [Abstract][Full Text] [Related]
10. Nutritional supplement practices in UK junior national track and field athletes.
Nieper A
Br J Sports Med; 2005 Sep; 39(9):645-9. PubMed ID: 16118303
[TBL] [Abstract][Full Text] [Related]
11. The use of drugs and nutritional supplements in top-level track and field athletes.
Tscholl P; Alonso JM; Dollé G; Junge A; Dvorak J
Am J Sports Med; 2010 Jan; 38(1):133-40. PubMed ID: 19812387
[TBL] [Abstract][Full Text] [Related]
12. Use of oral creatine as an ergogenic aid for increased sports performance: perceptions of adolescent athletes.
Ray TR; Eck JC; Covington LA; Murphy RB; Williams R; Knudtson J
South Med J; 2001 Jun; 94(6):608-12. PubMed ID: 11440329
[TBL] [Abstract][Full Text] [Related]
13. Caffeine improves physical and cognitive performance during exhaustive exercise.
Hogervorst E; Bandelow S; Schmitt J; Jentjens R; Oliveira M; Allgrove J; Carter T; Gleeson M
Med Sci Sports Exerc; 2008 Oct; 40(10):1841-51. PubMed ID: 18799996
[TBL] [Abstract][Full Text] [Related]
14. Distribution of caffeine levels in urine in different sports in relation to doping control.
Van Thuyne W; Roels K; Delbeke FT
Int J Sports Med; 2005 Nov; 26(9):714-8. PubMed ID: 16237615
[TBL] [Abstract][Full Text] [Related]
15. A false start in the race against doping in sport: concerns with cycling's biological passport.
Hailey N
Duke Law J; 2011 Nov; 61(2):393-432. PubMed ID: 22069854
[TBL] [Abstract][Full Text] [Related]
16. Health and doping in elite-level cycling.
Lentillon-Kaestner V; Hagger MS; Hardcastle S
Scand J Med Sci Sports; 2012 Oct; 22(5):596-606. PubMed ID: 21392123
[TBL] [Abstract][Full Text] [Related]
17. Consumption of dietary caffeine and coffee in physically active populations: physiological interactions.
Tunnicliffe JM; Erdman KA; Reimer RA; Lun V; Shearer J
Appl Physiol Nutr Metab; 2008 Dec; 33(6):1301-10. PubMed ID: 19088792
[TBL] [Abstract][Full Text] [Related]
18. Australian athletes' knowledge of the WADA Prohibited Substances List and performance enhancing substances.
Orr R; Grassmayr M; Macniven R; Grunseit A; Halaki M; Bauman A
Int J Drug Policy; 2018 Jun; 56():40-45. PubMed ID: 29550541
[TBL] [Abstract][Full Text] [Related]
19. Self-reported attitudes of elite athletes towards doping: differences between type of sport.
Alaranta A; Alaranta H; Holmila J; Palmu P; Pietilä K; Helenius I
Int J Sports Med; 2006 Oct; 27(10):842-6. PubMed ID: 16586338
[TBL] [Abstract][Full Text] [Related]
20. Problems of the use of pseudoephedrine by athletes.
Pokrywka A; Tszyrsznic W; Kwiatkowska DJ
Int J Sports Med; 2009 Aug; 30(8):569-72. PubMed ID: 19382058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
